Loading clinical trials...

Understanding COVID-19 Infection in Pregnant Women and Their Babies | Clinical Trials | Clareo Health

COMPLETED

Understanding COVID-19 Infection in Pregnant Women and Their Babies

NCT04703270•St George's, University of London

Summary

This national study will recruit expectant mothers with and without positive nasopharyngeal swabs for SARS-CoV-2, and aims to determine the seroepidemiology of SARS-CoV-2 amongst expectant mothers and their infants in the U.K.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Signed informed consent form
•Any woman pregnant in selected hospitals in England who has no signs or symptoms of COVID-19 disease during pregnancy and is rtPCR negative at delivery
•Any woman pregnant in any hospital in England who tests positive by rtPCR at any point during pregnancy from 24 weeks gestation onwards, regardless of signs and symptoms

Exclusion Criteria

•If the pregnant woman is under 18 years in prison or unable to make an informed consent for other reasons (e.g. learning difficulties, language barriers)

Locations (1)

St George's, University of London

London, United Kingdom

Key Dates

Start Date

January 4, 2021

Primary Completion Date

April 30, 2022

Completion Date

September 30, 2023

Last Updated

June 18, 2025

Enrollment

881

ACTUAL participants

Conditions

Corona Virus InfectionPregnancy RelatedNeonatal InfectionBreastfeeding

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

NCT06273683

Permanent SterilizationPregnancy Related

View study

RECRUITING

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

NCT06258902

Pregnancy Related

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Understanding COVID-19 Infection in Pregnant Women and Their Babies

Inclusion Criteria

Exclusion Criteria

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

Community-based Implementation of Adapted STAC

Dural Puncture Epidural vs Standard Epidural Analgesia in Labor

Effects of Systematic Cervical Exam Training on Labor and Delivery Care

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis